Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Evaluating the Effectiveness of an AI-powered Physician Assistant in Improving Patients' and Physician's Satisfaction in an Outpatient Setting of a Tertiary Care Hospital.

7. August 2026 aktualisiert von: Saqib Bakhshi, Aga Khan University

Patients' satisfaction depends on several factors, including health care costs, access to care, and the waiting time to see a healthcare professional. In Pakistan, hospitals face overcrowding, which in turn results in long waiting times, particularly in outpatient departments. Longer waiting times not only hurt patients' experience and hospitals' performance but also increase stress on the physicians.

These challenges can be addressed with the effective use of Artificial Intelligence (AI) and related technologies. By leveraging machine learning algorithms and advanced data prediction models, AI can augment healthcare providers in clinical decision-making and streamline their work processes. However, these applications are largely studied and implemented in high-income countries, creating a lack of evidence from low- and middle-income countries.

Hence, a randomized controlled trial will be conducted to assess the effectiveness of an AI physician assistant in improving patient and physician satisfaction within outpateint clincis of a resource constrained setting.

Studienübersicht

Status

Noch keine Rekrutierung

Intervention / Behandlung

Studientyp

Interventionell

Einschreibung (Geschätzt)

367

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

      • Karachi, Pakistan
        • Aga Khan University Hospital
        • Kontakt:
        • Kontakt:
        • Hauptermittler:
          • Saqib Bakhshi

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria (Patients):

  • Informed consent before enrolment.
  • Adults aged 18 years and above.
  • Initial patients registering at the clinic during the entire trial duration.
  • Possession of a digital device for an OTP (one-time password)
  • Can read and write Urdu and/or English

Inclusion Criteria (Physicians):

  • Informed Consent
  • Agree to include AI physician assistant in their workflows

Exclusion Criteria (Patients):

  • Patients requiring emergency care
  • Patients who refuse to complete the history process with the AI physician assistant.

Exclusion Criteria (Physicians):

- Physicians from non-surgical specialties

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: AI Physician Assistant

The intervention group will comprise participants enrolled in the application (AI physician assistant) in addition to the standard of care

The study participant allocated to the intervention will interact with the AI-physician assistant application "Hami" before they consult with the physician. The application will collect the medical history of the patient. This will then be followed by an AI-generated clinical summary, which their physicians will receive before the consultation begins. Physicians will review this summary and ask further questions of patients if required, and update the patient's record through an inbuilt scribe feature in the application.

The intervention evaluated here is an AI Physician Assistant. The assistant takes the patient's history using a specialty-specific line of questioning. Once the interaction ends, the application converts the information into an AI-generated clinical summary for physicians to review.

The physician reviews the summary and asks the patient additional questions, if required. Any additions or changes to the patient's history are recorded in the application. The physician then conducts a physical examination and can view AI-generated and guideline-based recommendations for assessment and treatment within the application. These recommendations may be selected, modified, or disregarded according to the physician's clinical expertise.

All additions to the patient's record can be entered manually or dictated verbally and automatically added through the application's ambient scribe feature. Once the treatment plan has been documented, the application generates a SOAP note.

Kein Eingriff: Standard of Care
The arm will comprise participants who receive standard care. In surgical clinics, standard care involves residents seeing the patients before the physicians. However, as part of the study, we will include physicians who agree to see patients without residents taking the history first. Hence, the trial uses the term 'physician' as part of the control group or standard care terminology.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Patient's satisfaction
Zeitfenster: Every day from each patient for a period of 2 months
Patient satisfaction is conceptualized through the lens of perceived quality of care, which is influenced by the effective utilization of waiting time and the provision of patient-centred care. Effective utilization of waiting time refers to patients' perceptions regarding whether their waiting time was used meaningfully during the visit. The domains of patient-centred care have been adapted from the Institute of Medicine (IOM) framework and include respect for patients' values and preferences, coordinated and integrated care, adequacy of information and communication, emotional support, involvement of family and friends, and physical comfort. These questions have been adapted based on the study objectives. The questionnaire will include demographic questions and five-point Likert-scale items (Strongly Agree to Strongly Disagree) and one open-ended question to obtain additional feedback regarding patients' experiences and satisfaction.
Every day from each patient for a period of 2 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Physician Satisfaction
Zeitfenster: From each physician at the end of each day for two months.

It will be assessed with regards to integration of an AI-powered physician assistant, focusing on usability, impact on workflow efficiency, evidence based treatment recommendations and improved patient-physician interaction.

Physician's satisfaction will be calculated utilizing mean scoring system, where each question will be scored on a 5 point Likert scale (Strongly Agree to Strongly Disagree). Additionally, we will ask one open-ended question at the end of the survey as part of physician satisfaction. This tool will be made exclusively for this study and will undergo content validation.

From each physician at the end of each day for two months.
Mean consultation time
Zeitfenster: Every day for each patient consultation for a period of 2 months

Consultation time (calculated in minutes) refers to the time taken by the physician while the patient is in the physician's room and the time taken by the physician for each of the following: to inquire about symptoms, conduct an examination, prescribe treatment, and provide counselling.

It will be measured using timestamps from a stopwatch from the time the patient enters the consultation room till the time they leave.

Every day for each patient consultation for a period of 2 months

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Process flow evaluation outcome - Mean queuing time
Zeitfenster: Every day for each patient visit for a period of 2 months

Mean queuing time for each patient before the consultation process begins. Queuing time (calculated in minutes) refers to the time spent by a patient in the waiting area after their registration has been completed till the start of their consultation.

It will be recorded using timestamps in two steps: one starting from the registration till the vitals are taken, secondly after vitals have been recorded till the patient visit the physician. These timings will be combined into a single aggregated time and will be calculated once for each patient.

Every day for each patient visit for a period of 2 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. September 2026

Primärer Abschluss (Geschätzt)

1. November 2026

Studienabschluss (Geschätzt)

1. November 2026

Studienanmeldedaten

Zuerst eingereicht

7. August 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

7. August 2026

Zuerst gepostet (Tatsächlich)

10. August 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

10. August 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

7. August 2026

Zuletzt verifiziert

1. Januar 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2026-12176-39541

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren